List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Active Pharma Ingredient Product Introduction
1.2 Market by Type
1.2.1 Global Active Pharma Ingredient Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Innovative Active Pharmaceutical Ingredients
1.2.3 Generic Active Pharmaceutical Ingredients
1.3 Market by Application
1.3.1 Global Active Pharma Ingredient Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cardiovascular Disease
1.3.4 Diabetes
1.3.5 Central Nervous System and Neurological Disorders
1.3.6 Endocrinology
1.3.7 Other Therapeutic Applications
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Active Pharma Ingredient Sales Estimates and Forecasts 2017-2028
2.2 Global Active Pharma Ingredient Revenue Estimates and Forecasts 2017-2028
2.3 Global Active Pharma Ingredient Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Active Pharma Ingredient Sales by Region
2.4.1 Global Active Pharma Ingredient Sales by Region (2017-2022)
2.4.2 Global Sales Active Pharma Ingredient by Region (2023-2028)
2.5 Global Active Pharma Ingredient Revenue by Region
2.5.1 Global Active Pharma Ingredient Revenue by Region (2017-2022)
2.5.2 Global Active Pharma Ingredient Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Active Pharma Ingredient Sales by Manufacturers
3.1.1 Global Top Active Pharma Ingredient Manufacturers by Sales (2017-2022)
3.1.2 Global Active Pharma Ingredient Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Active Pharma Ingredient in 2021
3.2 Global Active Pharma Ingredient Revenue by Manufacturers
3.2.1 Global Active Pharma Ingredient Revenue by Manufacturers (2017-2022)
3.2.2 Global Active Pharma Ingredient Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Active Pharma Ingredient Revenue in 2021
3.3 Global Active Pharma Ingredient Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Active Pharma Ingredient Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Active Pharma Ingredient Sales by Type
4.1.1 Global Active Pharma Ingredient Historical Sales by Type (2017-2022)
4.1.2 Global Active Pharma Ingredient Forecasted Sales by Type (2023-2028)
4.1.3 Global Active Pharma Ingredient Sales Market Share by Type (2017-2028)
4.2 Global Active Pharma Ingredient Revenue by Type
4.2.1 Global Active Pharma Ingredient Historical Revenue by Type (2017-2022)
4.2.2 Global Active Pharma Ingredient Forecasted Revenue by Type (2023-2028)
4.2.3 Global Active Pharma Ingredient Revenue Market Share by Type (2017-2028)
4.3 Global Active Pharma Ingredient Price by Type
4.3.1 Global Active Pharma Ingredient Price by Type (2017-2022)
4.3.2 Global Active Pharma Ingredient Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Active Pharma Ingredient Sales by Application
5.1.1 Global Active Pharma Ingredient Historical Sales by Application (2017-2022)
5.1.2 Global Active Pharma Ingredient Forecasted Sales by Application (2023-2028)
5.1.3 Global Active Pharma Ingredient Sales Market Share by Application (2017-2028)
5.2 Global Active Pharma Ingredient Revenue by Application
5.2.1 Global Active Pharma Ingredient Historical Revenue by Application (2017-2022)
5.2.2 Global Active Pharma Ingredient Forecasted Revenue by Application (2023-2028)
5.2.3 Global Active Pharma Ingredient Revenue Market Share by Application (2017-2028)
5.3 Global Active Pharma Ingredient Price by Application
5.3.1 Global Active Pharma Ingredient Price by Application (2017-2022)
5.3.2 Global Active Pharma Ingredient Price Forecast by Application (2023-2028)
6 North America
6.1 North America Active Pharma Ingredient Market Size by Type
6.1.1 North America Active Pharma Ingredient Sales by Type (2017-2028)
6.1.2 North America Active Pharma Ingredient Revenue by Type (2017-2028)
6.2 North America Active Pharma Ingredient Market Size by Application
6.2.1 North America Active Pharma Ingredient Sales by Application (2017-2028)
6.2.2 North America Active Pharma Ingredient Revenue by Application (2017-2028)
6.3 North America Active Pharma Ingredient Market Size by Country
6.3.1 North America Active Pharma Ingredient Sales by Country (2017-2028)
6.3.2 North America Active Pharma Ingredient Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Active Pharma Ingredient Market Size by Type
7.1.1 Europe Active Pharma Ingredient Sales by Type (2017-2028)
7.1.2 Europe Active Pharma Ingredient Revenue by Type (2017-2028)
7.2 Europe Active Pharma Ingredient Market Size by Application
7.2.1 Europe Active Pharma Ingredient Sales by Application (2017-2028)
7.2.2 Europe Active Pharma Ingredient Revenue by Application (2017-2028)
7.3 Europe Active Pharma Ingredient Market Size by Country
7.3.1 Europe Active Pharma Ingredient Sales by Country (2017-2028)
7.3.2 Europe Active Pharma Ingredient Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Active Pharma Ingredient Market Size by Type
8.1.1 Asia Pacific Active Pharma Ingredient Sales by Type (2017-2028)
8.1.2 Asia Pacific Active Pharma Ingredient Revenue by Type (2017-2028)
8.2 Asia Pacific Active Pharma Ingredient Market Size by Application
8.2.1 Asia Pacific Active Pharma Ingredient Sales by Application (2017-2028)
8.2.2 Asia Pacific Active Pharma Ingredient Revenue by Application (2017-2028)
8.3 Asia Pacific Active Pharma Ingredient Market Size by Region
8.3.1 Asia Pacific Active Pharma Ingredient Sales by Region (2017-2028)
8.3.2 Asia Pacific Active Pharma Ingredient Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Active Pharma Ingredient Market Size by Type
9.1.1 Latin America Active Pharma Ingredient Sales by Type (2017-2028)
9.1.2 Latin America Active Pharma Ingredient Revenue by Type (2017-2028)
9.2 Latin America Active Pharma Ingredient Market Size by Application
9.2.1 Latin America Active Pharma Ingredient Sales by Application (2017-2028)
9.2.2 Latin America Active Pharma Ingredient Revenue by Application (2017-2028)
9.3 Latin America Active Pharma Ingredient Market Size by Country
9.3.1 Latin America Active Pharma Ingredient Sales by Country (2017-2028)
9.3.2 Latin America Active Pharma Ingredient Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Active Pharma Ingredient Market Size by Type
10.1.1 Middle East and Africa Active Pharma Ingredient Sales by Type (2017-2028)
10.1.2 Middle East and Africa Active Pharma Ingredient Revenue by Type (2017-2028)
10.2 Middle East and Africa Active Pharma Ingredient Market Size by Application
10.2.1 Middle East and Africa Active Pharma Ingredient Sales by Application (2017-2028)
10.2.2 Middle East and Africa Active Pharma Ingredient Revenue by Application (2017-2028)
10.3 Middle East and Africa Active Pharma Ingredient Market Size by Country
10.3.1 Middle East and Africa Active Pharma Ingredient Sales by Country (2017-2028)
10.3.2 Middle East and Africa Active Pharma Ingredient Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Johnson & Johnson Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Overview
11.5.3 Mylan Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mylan Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Recent Developments
11.6 North China Pharmaceutical Group
11.6.1 North China Pharmaceutical Group Corporation Information
11.6.2 North China Pharmaceutical Group Overview
11.6.3 North China Pharmaceutical Group Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 North China Pharmaceutical Group Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 North China Pharmaceutical Group Recent Developments
11.7 Dr. Reddy?s Laboratories
11.7.1 Dr. Reddy?s Laboratories Corporation Information
11.7.2 Dr. Reddy?s Laboratories Overview
11.7.3 Dr. Reddy?s Laboratories Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Dr. Reddy?s Laboratories Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dr. Reddy?s Laboratories Recent Developments
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Overview
11.8.3 Roche Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Roche Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Roche Recent Developments
11.9 Aurobindo pharma
11.9.1 Aurobindo pharma Corporation Information
11.9.2 Aurobindo pharma Overview
11.9.3 Aurobindo pharma Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Aurobindo pharma Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aurobindo pharma Recent Developments
11.10 Sun Pharmaceutical Industries
11.10.1 Sun Pharmaceutical Industries Corporation Information
11.10.2 Sun Pharmaceutical Industries Overview
11.10.3 Sun Pharmaceutical Industries Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sun Pharmaceutical Industries Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sun Pharmaceutical Industries Recent Developments
11.11 Boehringer Ingelheim GmbH
11.11.1 Boehringer Ingelheim GmbH Corporation Information
11.11.2 Boehringer Ingelheim GmbH Overview
11.11.3 Boehringer Ingelheim GmbH Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Boehringer Ingelheim GmbH Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Boehringer Ingelheim GmbH Recent Developments
11.12 Bayer
11.12.1 Bayer Corporation Information
11.12.2 Bayer Overview
11.12.3 Bayer Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Bayer Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bayer Recent Developments
11.13 BASF
11.13.1 BASF Corporation Information
11.13.2 BASF Overview
11.13.3 BASF Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 BASF Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 BASF Recent Developments
11.14 DSM
11.14.1 DSM Corporation Information
11.14.2 DSM Overview
11.14.3 DSM Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 DSM Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 DSM Recent Developments
11.15 Zhejiang Medicine
11.15.1 Zhejiang Medicine Corporation Information
11.15.2 Zhejiang Medicine Overview
11.15.3 Zhejiang Medicine Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Zhejiang Medicine Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Zhejiang Medicine Recent Developments
11.16 Biocon
11.16.1 Biocon Corporation Information
11.16.2 Biocon Overview
11.16.3 Biocon Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Biocon Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Biocon Recent Developments
11.17 Johnson Matthey
11.17.1 Johnson Matthey Corporation Information
11.17.2 Johnson Matthey Overview
11.17.3 Johnson Matthey Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Johnson Matthey Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Johnson Matthey Recent Developments
11.18 Hisun Pharmacy
11.18.1 Hisun Pharmacy Corporation Information
11.18.2 Hisun Pharmacy Overview
11.18.3 Hisun Pharmacy Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Hisun Pharmacy Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Hisun Pharmacy Recent Developments
11.19 Cambrex
11.19.1 Cambrex Corporation Information
11.19.2 Cambrex Overview
11.19.3 Cambrex Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Cambrex Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Cambrex Recent Developments
11.20 Shandong Xinhua Pharmaceutical
11.20.1 Shandong Xinhua Pharmaceutical Corporation Information
11.20.2 Shandong Xinhua Pharmaceutical Overview
11.20.3 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Shandong Xinhua Pharmaceutical Recent Developments
11.21 Lonza group
11.21.1 Lonza group Corporation Information
11.21.2 Lonza group Overview
11.21.3 Lonza group Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Lonza group Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Lonza group Recent Developments
11.22 Huahai Pharmaceutical
11.22.1 Huahai Pharmaceutical Corporation Information
11.22.2 Huahai Pharmaceutical Overview
11.22.3 Huahai Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Huahai Pharmaceutical Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Huahai Pharmaceutical Recent Developments
11.23 Haerbin Pharmaceutical Group
11.23.1 Haerbin Pharmaceutical Group Corporation Information
11.23.2 Haerbin Pharmaceutical Group Overview
11.23.3 Haerbin Pharmaceutical Group Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Haerbin Pharmaceutical Group Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Haerbin Pharmaceutical Group Recent Developments
11.24 Cipla
11.24.1 Cipla Corporation Information
11.24.2 Cipla Overview
11.24.3 Cipla Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Cipla Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Cipla Recent Developments
11.25 Tian Yao
11.25.1 Tian Yao Corporation Information
11.25.2 Tian Yao Overview
11.25.3 Tian Yao Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 Tian Yao Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Tian Yao Recent Developments
11.26 Lupin
11.26.1 Lupin Corporation Information
11.26.2 Lupin Overview
11.26.3 Lupin Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.26.4 Lupin Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 Lupin Recent Developments
11.27 North East Pharmaceutical
11.27.1 North East Pharmaceutical Corporation Information
11.27.2 North East Pharmaceutical Overview
11.27.3 North East Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.27.4 North East Pharmaceutical Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.27.5 North East Pharmaceutical Recent Developments
11.28 Albemarle
11.28.1 Albemarle Corporation Information
11.28.2 Albemarle Overview
11.28.3 Albemarle Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.28.4 Albemarle Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.28.5 Albemarle Recent Developments
11.29 Shandong Lukang Pharmaceutical
11.29.1 Shandong Lukang Pharmaceutical Corporation Information
11.29.2 Shandong Lukang Pharmaceutical Overview
11.29.3 Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.29.4 Shandong Lukang Pharmaceutical Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.29.5 Shandong Lukang Pharmaceutical Recent Developments
11.30 Jiangsu Hengrui Medicine
11.30.1 Jiangsu Hengrui Medicine Corporation Information
11.30.2 Jiangsu Hengrui Medicine Overview
11.30.3 Jiangsu Hengrui Medicine Active Pharma Ingredient Sales, Price, Revenue and Gross Margin (2017-2022)
11.30.4 Jiangsu Hengrui Medicine Active Pharma Ingredient Product Model Numbers, Pictures, Descriptions and Specifications
11.30.5 Jiangsu Hengrui Medicine Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Active Pharma Ingredient Industry Chain Analysis
12.2 Active Pharma Ingredient Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Active Pharma Ingredient Production Mode & Process
12.4 Active Pharma Ingredient Sales and Marketing
12.4.1 Active Pharma Ingredient Sales Channels
12.4.2 Active Pharma Ingredient Distributors
12.5 Active Pharma Ingredient Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Active Pharma Ingredient Industry Trends
13.2 Active Pharma Ingredient Market Drivers
13.3 Active Pharma Ingredient Market Challenges
13.4 Active Pharma Ingredient Market Restraints
14 Key Findings in The Global Active Pharma Ingredient Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
